Eliot A. Phillipson

CentreStone Ventures Inc (CentreStone) is an independent venture capital firm founded in 2004. The firm is headquartered in Winnipeg, Manitoba.

BioQuebec is the largest biotechnology and life sciences network in Quebec, Canada. The private company is based in Bromont, Canada. BioQuebec's 130 members include companies and organizations that operate at every level of the biotechnology and life sciences innovation chain, ranging from biotechs to pharmas, contract research organizations, venture capital firms, and support organizations. The Canadian company engages in governmental representation, business development, and partnerships to support the growth of Quebec's biotechnology and life sciences industry, which creates wealth and specialized jobs, is focused on innovation and marketing, and is dedicated to improving everyone's health and quality of life. BioQuebec's actions aim to make Quebec one of the industry's most significant and valuable players on the international stage. The company was founded in 1991 by Pierre Alary, and the CEO is Mario Lebrun.

Tekna Plasma Systems, Inc. develops, designs and constructs integrated plasma systems. It offers nanoparticle synthesis, coating applications, and powder plasma treatments such as spheroidization and purification for laboratory research and industrial-scale processes. The firm provides spheroidization, nanopowder, deposition and aerospace equipment, nano and spherical powders, powder treatment and logistic options. The company was founded by Maher I. Boulos and Jerzy W. Jurewicz in 1990 and is headquartered in Sherbrooke, Canada.

Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA.

Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada.

McGill University Health Center provides health care services. The firm offers multidisciplinary patient centric care services. The company was founded in 1997 and is headquartered in Montreal, Canada.

Therillia Development Co., Inc. operates as a portfolio company of Sanderling Ventures. It develops novel drug candidates of interest to Sanderling and other venture capital investors from preclinical to clinical proof of concept. The company is headquartered in Montreal, Canada.

Gestion Univalor LP Provides research services. Its services include researcher services, and industry and investors services. The company was founded in 2001 and is headquartered in Montreal, Canada.

National Research Council of Canada, provides research & development. It services include research programs and collaboration opportunities, technical and advisory services, licensing opportunities and industrial research assistance program. The company was founded by Graham W. Burton and is headquartered in Ottawa, ON.

Vertex Pharmaceuticals (Canada), Inc. operates as a biotechnology company that invests in scientific innovation to create medicines for people with serious and life-threatening diseases. It discovered medicines to treat the cause of cystic fibrosis a genetic disease. The company is headquartered in Toronto, Canada.

Consortium Québécois sur la Découverte du Médicament (CQDM) is a not-for-profit biopharmaceutical research consortium based in Montréal, Canada. CQDM's mission is to support and facilitate multi-stakeholder collaborative R&D aimed at accelerating the translation of innovative technologies into solutions that address unmet medical needs, while generating significant benefits for the Quebec and Canadian economy. CQDM funds the development of innovative tools and technologies that accelerate the discovery and development of safer and more effective drugs. The company's Quantum Leap pharma-led funding program for drug discovery research helps SMEs or Canadian universities achieve innovative translational biopharmaceutical research projects. CQDM's SynergiQC-International program is designed to promote university-based industrial research in the biopharmaceutical field with collaborators outside, that will generate economic benefits. The non-profit company was founded by Max Fehlmann.

Diazon Pharmaceuticals, Inc. engages in the development of the onco-therapeutic DZ-2384 that targets a proven therapeutic pathway in oncology. The company was founded by Anne Roulston, Gordon Shore and Patrick Harran in 2013 and is headquartered in Montreal, Canada.

Immune Biosolutions, Inc. develops polyclonal, recombinant chicken antibodies, diagnostic tools, nutraceuticals and antibody based drugs to explore and resolve health issues. The firm’s products include light speed, sunrise, sunshine-in-a-box, eclipse blocking reagents and aurora detection reagents. The company was founded by Frédéric Leduc, Simon Gaudreau and Jean-François Larrivée in 2012 and is headquartered in Sherbrooke, Canada.

Univalor, Inc. engages in the provision of research and development services. The company was founded on April 27, 2001 and is headquartered in Montréal, Canada.

Quebec Blue Cross operates a not-for-profit organization. It offers travel and health insurance products. The company was founded in 1934 and is headquartered in Montreal, Canada.

Ontario Centres of Excellence, Inc. invests in research, commercialization & talent. The firm is a non-profit organization that drives the research to commercialization process. The company was founded in 2002 and is headquartered in Toronto, ON.

Montreal Economic Institute operates as a non-profit research and education organization. It aims at promoting economic education of the general public and efficient public policies. The firm research areas include different topics such as health care, education, taxation, labor, agriculture and the environment. The company is headquartered in Montr?al, Canada.

Part of The Hong Kong University of Science & Technology, Biotechnology Research Corp. engages in biotechnology research and development. The company is based in Hong Kong, Hong Kong.

Genesys Venture, Inc. operates as an investment firm, which specializes in health and biotechnology ventures. It offers life science accelerator services such as start-up, early-mid stage capitalization, business development, technology development, intellectual property management, and accounting and finance. The company was founded by Albert D. Friesen and Dawson J. Reimer in 1997 and is headquartered in Winnipeg, Canada.

Viventia Biotech, Inc. discovers, develops, manufactures, and commercializes monoclonal antibody products. Its products are used to treat head, neck, and bladder cancers. The company was founded by Albert D. Friesen in 1995 and is headquartered in Toronto, Canada

KAM Scientific, Inc. manufactures and distributes microbial disinfectant spray solutions for laboratories, hospitals, dental offices, clinics and various medical and public health related facilities. It offers Virocidin-X, a disinfectant and deodorizer for cleaning bacteria, fungus, and viruses. The company was founded by Albert D. Friesen and is headquartered in Winnipeg, Canada.

Magellan Biotech, Inc. provides private equity services to biotechnology companies.

MEDA Investments, Inc. is a private equity firm located in Waterloo, Ontario with additional offices in Winnipeg, Manitoba and Lancaster, Pennsylvania. The firm is a subsidiary of the Mennonite Economic Development Associates, an association that invests in the lives of families living in poverty around the world. MEDA Investments is a member of the Aspen Network of Development Entrepreneurs (ANDE), Canada's Venture Capital and Private Equity Association (CVCA), the International Association of Microfinance Investors (IAMFI) and the Social Investment Organization (SIO). MEDA Investments is a socially responsible international development investment organization. Their activities include microfinance and various other small and medium sized investment sectors that benefit poor communities. The firm provides access to private capital from developed countries and channels it to effective and sustainable business solutions to end poverty in developing countries. Investments are made through the Sarona Risk Capital Fund, Microvest or the Sarona Frontier Markets Fund. MEDA Investments also intermediates direct investments or private placements for investors on a project basis.

Marsala Biotech, Inc. engages in the discovery and development of drugs for cancer treatment. It offers E10A technology, an investigational gene therapy agent that utilizes an adenovirus vector to deliver the endostatin gene. The company is headquartered in Winnipeg, Canada.